Pegadria

Ibrutinib 140mg is a targeted therapy. It inhibits the function of Bruton's tyrosine kinase (BTK). BTK is a key signaling molecule of the B-cell receptor signaling complex that plays an important role in the survival of malignant B cells. It blocks signals that stimulate malignant B cells to grow and divide uncontrollably. It is not a chemotherapy drug but one of what are termed "targeted therapies."

Regorafenib 40mg Tablet is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.

Enzana is a medicine composition of Enzalutamide, which comes in capsules form and belongs to a class of drugs known as anti-androgens (anti-testosterone). This medicine works by blocking the effects of testosterone to slow the growth and spread of prostate cancer.